Patent · US Active

Expression vector and methods of producing high levels of proteins

US9163257B2 · kind B2 · utility

1Cited by

8References

19Claims

0Family size

Assignee

Cadila Healthcare Ltd. · IN

Inventors

Arun Kumar Singh · Fremont, US
Ashish Goel · Stanford, US
Sanjeev Kumar Mendiratta · Ahmedabad, IN

Key dates

Filing date	Jun 19, 2006
Grant date	Oct 20, 2015
Priority date	—
Expiry date	Oct 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/60
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A process for high expression of protein of interest using an expression vector. The process comprises at least the following regulatory elements: a) a CMV promoter, or its functional variants, b) an intron, c) TPL or its functional variants, d) VA genes or functional variants, and e) a bovine growth hormone polyadenylation sequence or functional variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.